TrialEuropean journal of heart failure2025

Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial.

Mark C Petrie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.